Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Marina Ripamonti"'
Autor:
Silvana Canevari, Delia Mezzanzanica, Rosaria Orlandi, Marina Ripamonti, Francisco Conde, Maria Ines Colnaghi
Publikováno v:
Advances in Oncology ISBN: 9781315076409
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e280a6708105b00e169f8f2fef5c1b33
https://doi.org/10.4324/9781315076409-9
https://doi.org/10.4324/9781315076409-9
Autor:
Antonio Guerriero, Marina Ripamonti, Michele D'Ambrosio, Jean Waikedre, Francesco Pietra, Cécile Debitus
Publikováno v:
Helvetica Chimica Acta. 79:727-735
Agelastatin A (1), an unusual alkaloid of the axinellid sponge Agelas dendromorpha from the Coral Sea, can be selectively acetylated (7) or methylated at OHC(8a) (4), peracetylated (8) or permethylated at OHC(8a), NH(5), and NH(6) (5), or, finally, s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b17f625e367a18f0c9dedc296b47ce9
https://doi.org/10.1002/hlca.19960790315
https://doi.org/10.1002/hlca.19960790315
Autor:
Laura Capolongo, Carlo Gornati, Antonino Suarato, Michele Caruso, Giulia Melegaro, Alberto Bargiotti, Maria Grandi, Marina Ripamonti
Publikováno v:
Investigational new drugs. 14(2)
The relationship between different chemical modifications on morpholinylanthracyclines and their ability to overcome multidrug resistance (MDR) has been evaluated testing all compounds in vitro on LoVo and LoVo/DX human colon adenocarcinoma cells and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6ad22f8f0fd851230396e06389254bd
https://pubmed.ncbi.nlm.nih.gov/8913834
https://pubmed.ncbi.nlm.nih.gov/8913834
Autor:
Michele Caruso, Faiardi Daniela, Francesco Angelucci, Cristina Geroni, Marina Ripamonti, Alberto Bargiotti, Antonino Suarato, Laura Capolongo, Maria Grandi
Publikováno v:
ACS Symposium Series ISBN: 9780841230408
Anthracycline Antibiotics: New Analogues, Methods of Delivery, and Mechanisms of Action
Anthracycline Antibiotics: New Analogues, Methods of Delivery, and Mechanisms of Action
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14eda7479739f2b635c2fad5d43eaede
https://doi.org/10.1021/bk-1995-0574.ch009
https://doi.org/10.1021/bk-1995-0574.ch009
Autor:
Marina Ripamonti, Nadia Amboldi, Dario Ballinari, Fabrizio Vaghi, Paolo Cozzi, Giulia Melegaro, Maria Grandi, Laura Capolongo
Publikováno v:
Acta oncologica (Stockholm, Sweden). 33(7)
The clinical use of Ca++ antagonist agents as modulators of multidrug resistance is limited by their strong vasodilator activity. This study reports data obtained by testing a series of new 1,4 dihydropyridine derivatives (DHPs) for their in vitro re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac3db439d2f17f9cedaa1f45c5e15bb3
https://pubmed.ncbi.nlm.nih.gov/7993647
https://pubmed.ncbi.nlm.nih.gov/7993647
Publikováno v:
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology. 18(4)
The in vivo behavior of the monoclonal antibody (MAb) MOv18, with a restricted specificity for human ovarian carcinoma was analyzed on normal and tumor-bearing animals. The pharmacokinetics of the iodine-labeled MAb carried out in BALB/c mice fits an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68cd3b3eda45a2a91209590f5be60f22
https://pubmed.ncbi.nlm.nih.gov/1864729
https://pubmed.ncbi.nlm.nih.gov/1864729
Autor:
Rosaria Orlandi, Maria I. Colnaghi, Silvana Canevari, Silvia Camagni, Delia Mezzanzanica, Marina Ripamonti
Publikováno v:
Europe PubMed Central
Scopus-Elsevier
Scopus-Elsevier
Three murine monoclonal antibodies (MoAbs), MBrl and MOv2 of IgM isotype and MOv8 of IgG isotype, with restricted reactivity for breast or ovarian carcinomas, were labelled with 125I in the perspective of obtaining specific and stable radioimmunophar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb8f8a7747081cb63f0e35f8c17e778f
https://doi.org/10.1177/030089168707300602
https://doi.org/10.1177/030089168707300602
Autor:
Sylvie Ménard, Rosaria Orlandi, Maria I. Colnaghi, Silvana Canevari, Salvatore Aguanno, Elda Tagliabue, Marina Ripamonti, Silvia Miotti
Publikováno v:
JNCI: Journal of the National Cancer Institute. 75:831-839
Ricin A chain was coupled to murine monoclonal antibodies MBr1 and MOv2 respectively raised against human breast and ovarian carcinomas. Inhibition of protein synthesis only occurred in those cultured human tumor cells bearing the appropriate target
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::256629105bdedd112f2968bb823028b4
https://doi.org/10.1093/jnci/75.5.831
https://doi.org/10.1093/jnci/75.5.831
Autor:
Silvia Miotti, Silvana Canevari, Marina Ripamonti, Maria I. Colnaghi, F. Leoni, Sandro Sonnino
Publikováno v:
Hybridoma. 5:289-296
The murine monoclonal antibody (MAb) MOv2 was found to be directed against the carbohydrate moieties of different kinds of molecules expressed on a human ovarian cystoadenocarcinoma. To define further the glycoconjugates carrying the MOv2-defined epi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74962bd663486dfd802859ee9cb58160
https://doi.org/10.1089/hyb.1986.5.289
https://doi.org/10.1089/hyb.1986.5.289
Autor:
Rosaria Orlandi, Francisco P. Conde, Marina Ripamonti, Delia Mezzanzanica, Pablo Jorge, Saturnino M. Muñoz, Maria I. Colnaghi, Silvana Canevari
Publikováno v:
Scopus-Elsevier
The protein toxin restrictocin, isolated from the mould Aspergillus restrictus, inactivates protein synthesis in eukaryotic cells by blocking the ribosome elongation cycle. This protein acts as a specific nuclease that cuts off a small fragment from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::567b7223607ba151fadc9a6d0c931c2d
https://doi.org/10.1111/j.1432-1033.1989.tb14511.x
https://doi.org/10.1111/j.1432-1033.1989.tb14511.x